GANGI, SARA
 Distribuzione geografica
Continente #
EU - Europa 1.426
AS - Asia 820
NA - Nord America 804
SA - Sud America 161
AF - Africa 26
OC - Oceania 5
Totale 3.242
Nazione #
US - Stati Uniti d'America 773
RU - Federazione Russa 521
IT - Italia 363
SG - Singapore 293
CN - Cina 219
IE - Irlanda 183
BR - Brasile 134
DE - Germania 105
HK - Hong Kong 83
KR - Corea 68
FI - Finlandia 53
FR - Francia 44
VN - Vietnam 43
GB - Regno Unito 41
IN - India 41
SE - Svezia 41
NL - Olanda 20
BD - Bangladesh 13
CZ - Repubblica Ceca 13
CA - Canada 12
MX - Messico 12
PL - Polonia 11
TR - Turchia 11
JP - Giappone 9
AR - Argentina 7
CI - Costa d'Avorio 7
AT - Austria 6
ES - Italia 6
MA - Marocco 6
PE - Perù 6
ZA - Sudafrica 6
CH - Svizzera 5
IQ - Iraq 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
PY - Paraguay 4
VE - Venezuela 4
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
UZ - Uzbekistan 3
DO - Repubblica Dominicana 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
ID - Indonesia 1
IM - Isola di Man 1
KE - Kenya 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NR - Nauru 1
PH - Filippine 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
UG - Uganda 1
Totale 3.242
Città #
Dallas 199
Singapore 192
Dublin 181
Moscow 163
Santa Clara 116
Hefei 85
Hong Kong 83
Lastra a Signa 66
Seoul 65
Munich 61
Ashburn 59
Beijing 58
Siena 44
Florence 35
Los Angeles 35
Milan 31
Bengaluru 27
New York 26
Chandler 25
Rome 21
Helsinki 20
Ho Chi Minh City 19
Düsseldorf 18
Turku 17
Lauterbourg 15
Nuremberg 13
Lappeenranta 11
Portsmouth 11
São Paulo 11
Warsaw 11
Redondo Beach 10
Southend 10
Hanoi 9
Shanghai 9
Boardman 8
Buffalo 8
Stockholm 8
Abidjan 7
Council Bluffs 7
Washington 7
Brno 6
Brooklyn 6
Chicago 6
Dhaka 6
London 6
Princeton 6
Tokyo 6
Ankara 5
Denver 5
Espoo 5
Frankfurt am Main 5
Lima 5
Málaga 5
North Bergen 5
Olomouc 5
Brasília 4
Johannesburg 4
Mexico City 4
Padova 4
Pescara 4
Phoenix 4
Portogruaro 4
Toronto 4
Amsterdam 3
Belo Horizonte 3
Campinas 3
Carpi 3
Chennai 3
Dubai 3
Fremont 3
Houston 3
Joinville 3
Livorno 3
Maracaibo 3
Montreal 3
Naples 3
Orem 3
Pisa 3
Querétaro 3
Raleigh 3
Rio de Janeiro 3
Risskov 3
San Francisco 3
San Jose 3
Shijiazhuang 3
Tashkent 3
Tehran 3
The Dalles 3
Turin 3
Zurich 3
Almaty 2
Amman 2
Auckland 2
Bari 2
Barrafranca 2
Bergamo 2
Bishkek 2
Bologna 2
Boston 2
Cagliari 2
Totale 2.016
Nome #
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 184
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 177
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 175
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 149
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 147
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 144
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 133
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 130
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 119
Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series 117
A multicenter study of extracellular vesicles profile in bronchoalveolar lavage from patients affected by IPF, HP and sarcoidosis 114
T helper and T cytotoxic cells subsets in peripheral, alveolar and lymph nodes of sarcoidosis patients 114
T follicular helper cell subsets in sarcoidosis patients: a comparison between three anatomical compartment 113
Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae 110
The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma 109
Nk and t cell immunological signatures in hospitalized patients with covid-19 106
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis 100
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 97
NK and T cells responses to CMV in patients awaiting for lung transplantation 93
Imbalance of Lymphocyte Subsets and CD45RA-Expressing Cells in Intrathoracic Lymph Nodes, Alveolar Compartment and Bloodstream of Pulmonary Sarcoidosis Patients 92
Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients 90
NK and T cell in patients with end-stage lung disorders waiting for lung transplantation in response to CMV infection 90
Immune-Checkpoint expression on CD4, CD8 and NK cells in blood, BAL and lymph nodes of sarcoidosis 89
Immunological pathways in sarcoidosis and autoimmune rheumatic disorders—similarities and differences in an Italian prospective real-life preliminary study 88
Diagnostic Performance of CLEIA Versus FEIA for KL-6 Peripheral and Alveolar Concentrations in Fibrotic Interstitial Lung Diseases: A Multicentre Study 86
Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis 82
Fibroblast-like culture from bronchoalveolar lavage of patient with idiopathic pulmonary fibrosis 75
Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease 73
Interleukin-6 and krebs von den lungen-6 in lymphangioleiomyomatosis patients 66
PD-1/TIGIT axis: a novel therapeutic target? 55
SAA and lipid metabolism in IPF 11
Translational Insights into T Cell Dysfunction and Precision Therapy in Idiopathic Pulmonary Fibrosis 10
Totale 3.338
Categoria #
all - tutte 11.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202233 0 0 0 0 0 2 1 1 0 11 6 12
2022/2023168 9 20 17 12 4 42 26 7 3 14 7 7
2023/2024397 11 16 32 21 16 55 115 32 9 17 33 40
2024/20251.183 99 55 131 49 127 46 51 83 98 63 111 270
2025/20261.557 200 279 231 339 490 18 0 0 0 0 0 0
Totale 3.338